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Abstract
Background: Nano- and microscale copper oxide particles (CuO NP, CuO MP) are applied for manifold purposes,
enhancing exposure and thus the potential risk of adverse health effects. Based on the pronounced in vitro cytotoxicity
of CuO NP, systematic investigations on the mode of action are required. Therefore, the impact of CuO NP, CuO MP
and CuCl2 on the DNA damage response on transcriptional level was investigated by quantitative gene expression
profiling via high-throughput RT-qPCR. Cytotoxicity, copper uptake and the impact on the oxidative stress response,
cell cycle regulation and apoptosis were further analysed on the functional level.
Results: Cytotoxicity of CuO NP was more pronounced when compared to CuO MP and CuCl2 in human bronchial
epithelial BEAS-2B cells. Uptake studies revealed an intracellular copper overload in the soluble fractions of both
cytoplasm and nucleus, reaching up to millimolar concentrations in case of CuO NP and considerably lower levels in
case of CuO MP and CuCl2. Moreover, CuCl2 caused copper accumulation in the nucleus only at cytotoxic concentrations.
Gene expression analysis in BEAS-2B and A549 cells revealed a strong induction of uptake-related metallothionein genes,
oxidative stress-sensitive and pro-inflammatory genes, anti-oxidative defense-associated genes as well as those coding for
the cell cycle inhibitor p21 and the pro-apoptotic Noxa and DR5. While DNA damage inducible genes were activated,
genes coding for distinct DNA repair factors were down-regulated. Modulation of gene expression was most pronounced
in case of CuO NP as compared to CuO MP and CuCl2 and more distinct in BEAS-2B cells. GSH depletion and activation
of Nrf2 in HeLa S3 cells confirmed oxidative stress induction, mainly restricted to CuO NP. Also, cell cycle arrest and
apoptosis induction were most distinct for CuO NP.
Conclusions: The high cytotoxicity and marked impact on gene expression by CuO NP can be ascribed to the strong
intracellular copper ion release, with subsequent copper accumulation in the cytoplasm and the nucleus. Modulation of
gene expression by CuO NP appeared to be primarily oxidative stress-related and was more pronounced in redox-
sensitive BEAS-2B cells. Regarding CuCl2, relevant modulations of gene expression were restricted to cytotoxic
concentrations provoking impaired copper homoeostasis.
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Background
Due to desired material properties such as high
temperature superconductivity, artificially synthesized
CuO nanoparticles (NP) are increasingly applied in
industry, for example as catalysts, additives in plastics
and metal coatings, but also as antimicrobial agents
(summarized in [1]). CuO microparticles (MP) are pre-
cursors during pigment production [2]. Furthermore,
CuO fumes including ultrafine particles are generated in
metal refining and processing [3–5].
In biological systems, copper represents the third com-
mon trace element next to zinc and iron. It serves as
catalytic cofactor in more than 30 metalloenzymes like
superoxide dismutase (SOD), cytochrome C oxidase
(COX), lysyl oxidase, dopamine-β-hydroxylase and ceru-
loplasmin, thus playing critical roles within manifold
biochemical pathways [6]. While the redox-activity is re-
quired for essential functions, copper ions may also be
toxic due to the catalysis of Fenton-type reactions, which
may lead to the formation of highly reactive hydroxyl
radicals, provoking oxidative damage to lipids, proteins
and DNA [7]. To ensure essential functions and to
largely prevent toxic reactions, both systemic as well as
cellular copper homoeostasis are tightly regulated by
copper binding to proteins and/or to small chelating
molecules, preventing the existence of “free” copper
ions. On the systemic level, copper homeostasis is regu-
lated via absorption in the small intestine and via
storage, distribution and biliary excretion by the liver,
avoiding overload or deficiency. Similarly, within cells,
copper levels and protein binding are strictly controlled
via uptake, storage, transfer and export proteins. Genet-
ically determined disturbances in copper homeostasis
lead to severe disease syndromes like Wilson’s or
Menke’s disease [8]. Nevertheless, copper overload can
also occur due to excessive uptake, for example via diet-
ary supplements, or due to non-physiological exposure
routes. While copper uptake occurs usually via food and
drinking water by the oral route, which is tightly regu-
lated, the situation may be different in case of inhalation
of copper fumes or aerosols in exposed workers, leading
potentially to cellular and/or systemic copper overload.
Different working groups reported an enhanced cyto-
toxic and genotoxic potential as well as a strong pro-
inflammatory response of CuO NP in various, mainly
lung-associated cell culture models when compared to
other metal-based nanoparticles [9–11] as well as to
bigger particles or water soluble copper compounds
[12–15]. Thus, besides the elemental composition dif-
ferent physico-chemical characteristics appear to con-
tribute to the pronounced toxicity. Important features
may include size, morphology, solubility, surface area
as well as the ability of the particles to associate with
biomolecules from the environment to form a protein
corona [16], with potential impact on interactions of
the particles with cellular membranes, uptake and
intracellular bioavailability, finally leading to elevated
levels of ROS.
One explanation originally proposed by Limbach and
co-authors in 2007 in case of Co3O4 nanoparticles and
since then strengthened in several studies e.g. by Karls-
son and co-workers for CuO NP has been termed the
“Trojan horse type mechanism”. It proposes the endo-
cytotic uptake of the particles and the processing of the
resulting vesicles into acidic lysosomes, thus affecting
the degree of metal release from the particles and pro-
voking potential intracellular overload conditions
[12–15, 17–19]. Supporting this theory, many NP
have been reported to use endocytotic mechanisms
as major import pathway into the cell [20–23], in-
cluding nanosized CuO in A549 cells [19].
However, many aspects still need to be elucidated.
Thus, while the high cytotoxicity of CuO NP has been
repeatedly demonstrated, less attention has been given
to the impact on genomic stability. Furthermore, also
the degree and intracellular distribution of deliberated
copper ions is still not known. With respect to the latter,
copper uptake has frequently been determined in whole
cells, baring the risk of irrelevant results due to
remaining and barely removable particles at the outer
membrane.
Within the present study, we used adenocarcinoma
A549 and BEAS-2B lung cells since the lung is the major
target organ of CuO NP toxicity upon inhalative expos-
ure to assess the impact on the DNA damage response
system and to link it to intracellular copper levels upon
copper particle or water soluble copper exposure. In a
previous study of our working group, a detailed investi-
gation on the cyto- and genotoxicity as well as copper
uptake of CuO NP as compared to CuO MP and CuCl2
was performed in A549 cells, demonstrating pronounced
cytotoxicity in case of CuO NP and CuCl2, but no effect
in case of CuO MP. Furthermore, apoptosis induction as
well as the induction of DNA strand breaks analysed in
the model cell line HeLa S3 were restricted to CuO NP.
Also, strongest impairment of the DNA damage signal-
ling reaction poly(ADP-ribosylation) mediated predomi-
natly by poly(ADP-ribose) polymerase 1 was observed in
case of CuO NP. Finally, highest intracellular copper
levels, both in the cytoplasm and the nucleus, were
found in case of CuO NP [14]. Following up on this in-
vestigation in A549 cells, the central aspect of the
present study was to elucidate the impact of all three
copper compounds on gene expression profiles by using
a recently established high-throughput RT-qPCR system
via the BioMark™ device. This procedure enables the
parallel assessment of the impact of 96 samples on 95
genes crucial for maintaining genomic stability,
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consisting of selected genes coding for stress response,
DNA damage response, specific DNA repair factors, cell
cycle control, apoptosis and mitotic signalling [24]. The
effects of CuO NP were compared with those evoked by
CuO MP and water soluble CuCl2 in identical mass
doses to differentiate between particle, nano-particle and
copper-mediated effects. In addition to A549 cells we in-
cluded BEAS-2B cells as a second lung cell model. Both
cell lines display advantages and disadvantages; A549
cells are p53 proficient but as a tumor cell line they have
lost some characteristics of the original epithelial type 2
cells and they display some persistent basal signalling
deregulation. In contrast, BEAS-2B cells are non-
tumorigenic, but functionally p53 deficient due to the
immortalization [25]. Thus, the comparison of the two
cell lines with different transformation status and the
knowledge about their respective limitations may pro-
vide valuable hints for evaluating and interpreting the ef-
fects on gene expression profiles. Finally, different
outcomes on the transcriptional response were followed
up on the functional level, such as the impact on the




The particulate copper compounds CuO NP and CuO
MP were characterized in detail with respect to size, sur-
face area and charge, chemical composition, crystallinity
and morphology via dynamic light scattering (DLS),
scanning electron microscopy (SEM), Brunauer-Emmet-
Teller (BET) analysis, zeta potential (ZP), inductively
coupled plasma mass spectrometry (ICP-MS), energy-
dispersive X-ray spectroscopy (EDX) as well as X-ray dif-
fraction (XRD) as previously described. Briefly, CuO NP
as well as CuO MP were of high purity and of the same
composition, free of endotoxins and did not alter the pH
of cell culture media. CuO NP were approximately
spherical, displayed a narrow size range (20–200 nm),
showed a surface area of 17.23 m2/g with a calculated
average diameter of 55 nm and were agglomerated in
fluids. DLS measurements revealed a size distribution
around 146 nm and a ZP of −13.1 mV in DMEM/FCS.
CuO MP had a size distribution of 500 nm −10 μm, a
surface area of 0.74 m2/g and a calculated average of
1289 nm. DLS analysis was not possible due to fast sedi-
mentation of the particles [14].
Cytotoxicity
The impact on the cell number of BEAS-2B cells after
24 h incubation with CuO NP, CuO MP and CuCl2 was
determined as a measure of cytotoxicity and to establish
appropriate incubation conditions for subsequent analyses
(Fig. 1). This approach was chosen since these cells do not
form colonies and an interference by copper ions and
copper-based particles with dye-based toxicity assays has
been reported previously [26]. CuO NP provoked a strong
concentration-dependent decrease of cell number. Thus,
in case of 5 μg/mL a reduction to 79% compared to con-
trol was observed, reaching 30% and 10% in case of 20 μg/
mL or 50 μg/mL, respectively. In contrast, incubation with
CuO MP resulted in cell numbers above 80% up to 20 μg/
mL and only in case of 50 μg/mL a pronounced reduction
to 64% was observed. CuCl2 was only weakly cytotoxic
with a maximum decrease of cell number to 81% through-
out the analysed concentration range. In A549 cells the
cytotoxicity of the same compounds has been investigated
by colony forming ability and published previously; here,
most pronounced cytotoxicity was also observed in case
of CuO NP followed by CuCl2, whereas CuO MP were
not cytotoxic throughout the analysed concentration
range. As opposed to BEAS-2B cells, CuCl2 exhibited
starting cytotoxicity at the lowest concentration tested, i.e.
63 μM corresponding to 5 μg/mL [14]. On the basis of
these cytotoxicity results, subsequent investigations were
performed mainly up to 20 μg/mL CuO and 252 μM
CuCl2, respectively.
Cellular uptake and intracellular distribution of copper
Cellular uptake and intracellular distribution of copper
was analysed after 24 h incubation with different con-
centrations of CuO NP, CuO MP and CuCl2 via graphite
furnace atomic absorption spectrometry (GF-AAS).
When working with particles, one problem consists in
the fact that particles attach and stick to the outer mem-
brane, which may provide artefacts when determining
the intracellular copper content. Thus, a special proced-
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Fig. 1 Cytotoxicity of CuO NP, CuO MP and CuCl2. Cytotoxicity was
determined via cell number after 24 h treatment with the different
copper compounds in BEAS-2B cells. Shown are mean values of six
determinations derived from three independent experiments ± SD.
Statistically significant different from control: *p ≤ 0.05, **p ≤ 0.01,
***p ≤ 0.001 (ANOVA-Dunnett’s T test)
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soluble fractions of the whole cell, the cytoplasm and
the nucleus [14, 27].
As shown in Fig. 2a, the basal copper concentration in
BEAS-2B cells was found to be 20 μM. Treatment with
CuO NP resulted in a pronounced dose-dependent accu-
mulation of intracellular copper. As low as 1 μg/mL pro-
voked an 18-fold accumulation to 330 μM copper. After
treatment with 5 μg/mL and higher intracellular concen-
trations up to 2 mM were observed. CuO MP also pro-
voked a concentration-dependent but less pronounced
increase in intracellular copper, resulting in a maximum
of 330 μM. Incubation with CuCl2 was found to result in
almost constant intracellular levels of 250–400 μM cop-
per within the applied concentration range up to
252 μM.
The analysis of the cytoplasmic copper levels revealed
a similar picture. Treatment with CuO NP resulted in
copper levels of up to 1.7 mM in case of 20 μg/mL.
Treatment with CuO MP displayed less pronounced
dose-dependent increases in cytoplasmic copper as com-
pared to CuO NP; at the highest dose, however, copper
levels were higher than in the whole cells. This may be
due to higher variations due to inhomogeneous particle
uptake; thus, small differences in endocytosed particle
numbers would be expected to result in pronounced dif-
ferences in intracellular copper levels. Treatment with
CuCl2 again revealed comparatively small increases up
to 400 μM (Figure 2b). The basal copper concentration
within the nuclear fraction of BEAS-2B cells was about
11 μM. Most strikingly, almost no increase in copper
concentrations was observed in case of CuCl2, while
CuO NP led to a markedly increased accumulation of
nuclear copper up to 3 mM; this was even higher when
compared to the cytoplasm. Intermediate levels were
found in case of CuO MP. The cytoplasmic and nuclear
copper levels add very well to the copper accumulation
of the total cell. Since the volume of the nucleus ac-
counts for only 10% of the cell volume, the cytoplasmic
concentration should be close to the total cell volume.
For example, in case of 20 μg/mL CuO NP respective
values were 2000 μM (total), 1700 μM (cytoplasm),







































































































Fig. 2 Cellular copper uptake and intracellular copper distribution
after treatment with CuO NP, CuO MP and CuCl2. Copper content
was determined in the soluble fraction of the total cell (a), the
cytoplasm (b) and the nucleus (c) in BEAS-2B cells after 24 h treat-
ment with the different copper compounds via GF-AAS. Shown are
mean values of three independent experiments + SD ((a) and CuO
NP (b,c)), mean values of six independent experiments + SD (10 μg/
mL CuO NP (b,c)) or mean values of two independent experiments
+ R/2 (CuO MP and CuCl2 (b, c)). Statistically significant different
from control: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 performed in case
of (a) and CuO NP (b, c) (ANOVA-Dunnett’s T test). 20 μg/mL CuO
are equal to 252 μM Cu2+. n.d.: not determined
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results in an average concentration of 1830 μM, which
fits quite reasonable to the copper content of the total
cell. Similar agreements were found for the other con-
centrations applied.
Additionally, we quantified the copper content in
whole cells including the outer membrane to get an im-
pression of particles sticking to it, applying doses of
10 μg/mL CuO NP and CuO MP (Additional file 1).
When not excluding the membrane, copper concentra-
tion was elevated more than 3.5-fold from 1350 μM up
to 4800 μM in case of CuO NP and even more pro-
nounced to more than 70-fold from 300 μM up to
22,000 μM in case of CuO MP. These findings demon-
strate the importance of removing the membranes since
otherwise the copper uptake would be considerably
overestimated.
In A549 cells the copper uptake into cytoplasm and
nucleus has been investigated previously; here, CuO NP
and CuCl2 led to a concentration-dependent copper in-
crease in the cytoplasm, even though less accumulation
was seen when compared to BEAS-2B cells. In contrast,
CuO MP led to higher, albeit highly variable cytoplasmic
concentrations in A549 cells. With respect to the copper
concentrations in the nucleus, effects of CuO NP and
CuO MP were similar in A549 and BEAS-2B cells; in
case of CuCl2, elevated copper levels were detected only
in the former cell line, coincident with higher cytotox-
icity [14].
Gene expression analyses
The impact of CuO NP, CuO MP and CuCl2 on gene ex-
pression profiles related to genomic stability was investi-
gated in BEAS-2B and A549 cells after 24 h incubation
via a high-throughput RT-qPCR technique [24]. The
main observations obtained in both cell lines sorted in
distinct signalling pathways and cellular processes are
described in the following sections.
Impact on genes related to copper uptake and (oxidative)
stress response
The three copper compounds induced a pronounced
dose-dependent up-regulation of the metallothionein
genes MT1X and MT2A (Fig. 3). Strongest induction
was evident by CuO NP in BEAS-2B cells (Fig. 3a).
MT1X was transcriptionally enhanced to 9-fold at 1 μg/
mL and increasing to 29-fold at 20 μg/mL, whereas
mRNA levels of MT2A were elevated up to 8-fold. The
expression of these genes was also induced by CuO MP
and CuCl2, albeit to a lesser extent, reaching 12-fold
(MT1X) and 3-fold (MT2A) increases in case of CuO
MP and CuCl2, respectively. In A549 cells (Fig. 3b) the
increase of transcript levels was less pronounced as
compared to BEAS-2B cells; both genes were induced
dose-dependently in case of CuO NP up to 11- and 4-
fold, respectively, while CuO MP showed no effect.
CuCl2 enhanced transcription to a similar extent as CuO
NP; however, induction was restricted to higher concen-
trations exerting considerable cytotoxicity in this cell
line [14].
An induction of the oxidative stress response system
at the transcriptional level was again most pronounced
after treatment with CuO NP, with strongest effects in
BEAS-2B cells (Fig. 4). Thus, in BEAS-2B cells expres-
sion of the ROS-inducible gene HMOX1 was up-
regulated concentration-dependently up to 53-fold by
CuO NP and up to 10-fold by the other copper com-
pounds. Transcription of the heat-shock sensitive
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Fig. 3 Impact of CuO NP, CuO MP and CuCl2 on gene expression of MT1X and MT2A related to copper uptake. BEAS-2B cells (a) or A549 cells (b)
were treated with the different copper compounds for 24 h. Shown are linear fold changes of the relative gene expression from mean values of
four determinations derived from two independent experiments ± SD. 20 μg/mL CuO are equal to 252 μM Cu2+. Please note the different scaling
of the y-axis
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CuO NP or CuO MP, respectively, whereas no effects
were observed after treatment with CuCl2 (Fig. 4a). In
A549 cells HMOX1 and HSPA1A were almost equally
enhanced by CuO NP on the transcriptional level to a
maximum of 8-fold or 7-fold, respectively. CuCl2 and
CuO MP induced no changes in gene expression, except
for HMOX1 in case of CuCl2 at the highest concentra-
tion (Fig. 4b).
Induction of inflammation marker IL8 was also far
more pronounced in BEAS-2B cells as compared to
A459 cells and most evident after treatment with CuO
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Fig. 4 Impact of CuO NP, CuO MP and CuCl2 on gene expression of HMOX1 and HSPA1A related to oxidative stress response. BEAS-2B cells (a) or
A549 cells (b) were treated with the different copper compounds for 24 h. Shown are linear fold changes of the relative gene expression from
mean values of four determinations derived from two independent experiments ± SD. 20 μg/mL CuO are equal to 252 μM Cu2+. Please note the
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Fig. 5 Impact of CuO NP, CuO MP and CuCl2 on gene expression of inflammation marker IL8. BEAS-2B cells (a) or A549 cells (b) were treated with
the different copper compounds for 24 h. Shown are linear fold changes of the relative gene expression from mean values of four determinations
derived from two independent experiments ± SD. 20 μg/mL CuO are equal to 252 μM Cu2+. Please note the different scaling of the y-axis
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than 100-fold increase in gene expression, while CuO
MP and CuCl2 induced transcription only up to 16-
fold or 4-fold, respectively. In A549 cells IL8 expres-
sion was activated 3-fold (CuO NP), 4-fold (CuCl2) or
2-fold (CuO MP); again CuCl2 displayed a slightly
stronger effect than CuO NP, but restricted to cyto-
toxic concentrations.
Impact on genes related to anti-oxidative defense, cell cycle
regulation, apoptosis and DNA damage response and repair
The impact of CuO NP, CuO MP and CuCl2 on genes
associated to the anti-oxidant defense system, cell cycle
regulation and proliferation, apoptosis as well as DNA
damage response and repair in both cell lines is summa-
rized in a heat map view (Fig. 6). In contrast to the gene
expression results shown above, changes in gene expres-
sion are presented as log2-fold changes with a value of 0
for the untreated control since a repression of transcrip-
tion frequently observed within these signalling groups
became clearer within this depiction.
Most strikingly, strong modulations were observed in
case of CuO NP already evident at the lowest concentra-
tion in BEAS-2B cells. Thus, a strictly dose-dependent
induction of genes coding for anti-oxidative enzymes
like FTH1, GCLC, GSR, NQO1, PRDX1, SOD1 and
TXNRD1, as well as of the proliferation-associated JUN,
MYC, PLK3 genes along with the induction of cell cycle
inhibitor gene CDKN1A was observed in case of CuO
NP in this cell line. Likewise, expression levels of the
pro-apoptotic genes PMAIP1 and TNFRSF10B were in-
duced together with enhanced transcription of the anti-
apoptotic BCL2 and BCL2L1 genes, affecting both the
extrinsic and the intrinsic pathway. Concerning the
DNA damage response, transcription of the damage in-
ducible genes DDIT3 and GADD45A was increased.
However, the expression of specific DNA repair genes
like the BER-associated LIG1, OGG1 and PARP1, the
NER-associated DDB2 and XPC genes as well as PCNA
was repressed by CuO NP in a concentration-dependent
manner. With respect to CuO MP almost no modulation
of the above mentioned genes was observed in BEAS-2B
cells; by tendency altered transcript levels were at most
restricted to the highest concentration. Intermediate
effects occurred in case of CuCl2. Some anti-oxidative
defense-associated as well as apoptosis related genes
were induced together with a moderate induction of
DDIT3 and GADD45A, while in case of the DNA repair
genes only by tendency repressed transcript levels were
observed. Most notably, no dose-dependency was
obvious in case of CuCl2, since most relevant changes
occurred in case of 126 μM and not 252 μM.
In A549 cells a completely different gene expression
pattern was apparent. In case of CuO NP mainly re-
pressed transcript levels were observed, especially with
respect to the anti-oxidative defense-associated genes.
Only genes coding for the cell cycle inhibitor p21
(CDKN1A), the pro-apoptotic Noxa (PMAIP1) and the
DNA damage inducible DDIT3 (DDIT3) were transcrip-
tionally slightly enhanced after treatment with CuO NP.
With respect to pro-apoptotic signalling, effects were re-
stricted to the intrinsic pathway (PMAIP1), along with
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Fig. 6 Impact of CuO NP, CuO MP and CuCl2 on gene expression related to anti-oxidative defense, cell cycle regulation, apoptosis and DNA damage
response and repair. BEAS-2B cells or A549 cells were treated with the different copper compounds for 24 h. Shown are log2-fold changes of the rela-
tive gene expression in a heat map view from mean values of four determinations derived from two independent experiments (value of
control = 0). 20 μg/mL CuO are equal to 252 μM Cu2+. n.d.: not determined
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genes BCL2 and BCL2L1. No effects at all were observed
in case of CuO MP. CuCl2 displayed a gene expression
modulation largely comparable to CuO NP; however, in
contrast to CuO NP, pronounced effects were restricted
to the highest, already cytotoxic concentration.
Intracellular GSH content
The induction of oxidative stress was investigated via
modulations of the intracellular GSH levels after treat-
ment with CuO NP, CuO MP and CuCl2 in BEAS-2B
cells according to the method established by Tietze [28].
CuO NP led to slightly reduced intracellular GSH levels
to 80% of control beginning at 10 μg/mL after 2 h
(Fig. 7a). In contrast, CuO MP or CuCl2 displayed no
alterations at this time point. After a 24 h treatment
period no changes were observed in case of the par-
ticulate copper compounds; however, CuCl2 displayed
a pronounced increase up to 150–170% in the con-
centration range of 63–252 μM (Fig. 7b).
Nrf2 activation
Furthermore, a potential activation of the redox-
sensitive transcription factor Nrf2 was examined. Since
nuclear Nrf2 levels were too low for quantification in
BEAS-2B cells when using a reasonable cell number and
A549 cells on the other hand exert a constitutively acti-
vated Nrf2 due to a dysfunction of its negative inhibitor
Keap1 [29], these investigations were performed in HeLa
S3 cells as a model. Experiments were accomplished by
a TransAm Nrf2 ELISA assay, quantifying the binding
capacity of nuclear located Nrf2 to the ARE consensus
binding site (Fig. 8). Considering the time point of most
pronounced activation of Nrf2 by the positive control
sulforaphane (data not shown), cells were treated for 5 h
with the respective copper compounds applying a con-
centration range from 5 to 40 μg/mL in case of CuO NP
and CuO MP, or 63–504 μM in case of CuCl2. The con-
centrations were selected based on cytotoxicity of the
copper compounds in this cell line as previously pub-
lished [14]. While CuO MP were not cytotoxic within
the entire concentration range applied, CuO NP and
CuCl2 exerted strong cytotoxicity starting at 5 μg/mL or
126 μM, respectively. Furthermore, uptake studies with
the copper compounds were performed in this cell line
to assess the suitability as a model for Nrf2 activation
(Additional file 2). Here, a concentration-dependent in-
crease of intracellular copper levels reaching more than
2.5 mM was observed in case of CuO NP after 8 h and
24 h; copper accumulation was even more pronounced
as compared to BEAS-2B cells. In contrast, copper levels
were not altered by CuCl2 or CuO MP except for the
high concentration of 50 μg/mL. Consequently, since
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Fig. 7 Impact of CuO NP, CuO MP and CuCl2 on the intracellular
GSH level. BEAS-2B cells were treated for 2 h (a) or 24 h (b), respect-
ively, with the different copper compounds. Shown are mean values
of four determinations derived from two independent experiments
± SD. Statistically significant different from control: *p ≤ 0.05, **p ≤ 0.01
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Fig. 8 Impact of CuO NP, CuO MP and CuCl2 on Nrf2 activity. HeLa
S3 cells were treated for 5 h with the different copper compounds.
Shown are mean values of three independent experiments + SD.
Statistically significant different from control: ***p ≤ 0.001
(ANOVA-Dunnett’s T test). 20 μg/mL CuO are equal to 252 μM Cu2+
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comparable to BEAS-2B and A549 cells the use of
HeLa S3 cells as a model was acceptable. Only CuO
NP induced a strong activation of Nrf2 of 180–210%
within the entire concentration range, whereas no ac-
tivation of the transcription factor was observed in
case of CuO MP; CuCl2-induced activation was restricted
to the highest, cytotoxic concentration of 504 μM.
Cell cycle distribution and apoptosis
The impact of CuO NP, CuO MP and CuCl2 on cell
cycle distribution, apoptosis and necrosis at different
times was investigated via flow cytometry in BEAS-2B
cells. Cell cycle analyses were performed using the DNA
intercalating fluorescent dye DAPI and the distinction
between viable, apoptotic and necrotic cells took
place using annexin V-FITC and propidium iodide
(PI) staining.
The effect on cell cycle distribution was most evident
after 8 h (Fig. 9). Thus, CuO NP led to a dose-
dependent increase of cells in G0/G1 phase from 40% in
the control up to more than 50% in case of 20 μg/mL.
The amount of S phase cells did not alter, but cells in
G2/M phase decreased accordingly. CuO MP and CuCl2
affected the cell cycle distribution in a similar manner.
However, the modulation occurred to a lesser extent
with relevant effects restricted to high concentrations
starting at 20 μg/mL or 252 μM, respectively. After 24 h
no alteration within cell cycle distribution was persistent
(Additional file 3).
With respect to cell death induction, only weak effects
were observed after 24 h (Additional file 4), whereas
a distinct modulation was obvious after 48 h (Fig. 10).
Thus, incubation with CuO NP concentration-
dependently enhanced the amount of apoptotic cells
to a maximum of nearly 10%, whereas CuO MP and
CuCl2 displayed a maximum of 4% apoptotic cells.


























































Fig. 9 Impact of CuO NP, CuO MP and CuCl2 on cell cycle distribution. BEAS-2B cells were treated with the different copper compounds for 8 h.
Shown are mean values of four determinations derived from two independent experiments + SD. Statistically significant different from control:
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 (ANOVA-Dunnett’s T test). The numbers right to each bar indicate the fraction of cells in the respective phase.







































































Fig. 10 Induction of apoptosis (a) and necrosis (b) after treatment
with CuO NP, CuO MP and CuCl2. BEAS-2B cells were treated with
the different copper compounds for 48 h. Shown are mean values
of four determinations derived from two independent experiments
+ SD. Statistically significant different from control: *p ≤ 0.05,
**p ≤ 0.01, ***p ≤ 0.001 (ANOVA-Dunnett’s T test). 20 μg/mL CuO
are equal to 252 μM Cu2+. n.d.: not determined
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of CuO NP and 2% in case of CuO MP and CuCl2.
Altogether, cell death was mediated about equally by
apoptosis and necrosis.
Discussion
Within the present study, cytotoxicity, cellular uptake
and intracellular copper accumulation after treatment
with CuO NP as compared to CuO MP and water sol-
uble CuCl2 were investigated in the immortalized human
bronchial epithelial cell line BEAS-2B and compared to
findings in the adenocarcinoma cell line A549 previously
performed in our working group [14]. Moreover, the im-
pact on cellular signalling pathways involved in the
maintenance of genomic stability was analysed in both
cell lines by systematic, concentration-dependent gene
expression profiling via a high-throughput RT-qPCR
approach. Some observations on mRNA level were
pursued on the functional level by investigating induc-
tion of apoptosis, oxidative stress as well as modulation
of cell cycle distribution in BEAS-2B cells. Main out-
comes were a distinct accumulation of copper in the
soluble fractions of the cytoplasm and the nucleus after
treatment with CuO NP, leading to pronounced changes
in gene expression related to metallothionein induction,
oxidative stress response, DNA damage response, cell
cycle regulation and apoptosis. Far less effects were
observed in case of CuO MP. Interestingly, CuCl2 led to a
copper accumulation in the cytoplasm, but not in the
nucleus, and cellular effects were mainly restricted to cyto-
toxic concentrations with disturbed copper homeostasis.
The stronger cytotoxicity of CuO NP when compared
to CuO MP or CuCl2 confirmed previous observations
on the cytotoxicity of differently sized CuO particles and
water-soluble copper compounds in lung-associated cell
models [12, 13, 15, 30]. Additionally, CuO NP exerted
more pronounced cytotoxic effects in BEAS-2B than in
A549 cells, even though in the latter cell line the more
sensitive colony forming ability was applied [14]. The
higher sensitivity of BEAS-2B cells towards CuO NP as
compared to A549 cells was also reported by Cronholm
and colleagues [12]. This may be due to the higher GSH
content of A549 compared to BEAS-2B cells [31–33].
However, interestingly, cytotoxicity of CuCl2 was higher
in the former cell line.
As stated in the introduction, the major mechanism
proposed for the high toxicity of CuO NP consists in the
so-called “Trojan horse type mechanism” [17], compris-
ing the endocytotic uptake of the particles, the solubil-
isation in lysosomes and the subsequent intracellular
copper ion release. Endocytosis of particulate CuO has
been shown in several studies [20–23]. While electron
microscopy enables the detection of particles inside the
cell and thus can demonstrate particle uptake, it does
not allow an exact quantification of endocytosed
particles. Considering the whole cell, a more efficient
uptake of CuO NP in BEAS-2B cells as compared to
A549 cells was already shown previously, determined by
AAS [12]. However, since particles tend to bind to cell
membranes and cannot be removed completely by cell
washing, quantification of copper content of treated cells
by AAS or ICP-MS does not allow to discriminate be-
tween copper within particles attached to the cells and
deliberated copper ions inside the cell. Within the
present study, therefore, copper was quantified by AAS,
measuring total copper contents in cells and additionally
by applying a specific two step lysis procedure. With re-
spect to the latter, an approach has been chosen where
the plasma membrane was lysed in the first step, yield-
ing the soluble cytoplasmic fraction and cell nuclei.
These were lysed in the second step, yielding the soluble
fraction of the nuclei. Concerning the intracellular distri-
bution, a strictly concentration-dependent copper accu-
mulation up to millimolar concentrations both in the
cytoplasm and even more pronounced in the nucleus
was shown for the first time for CuO NP in BEAS-2B
cells, exceeding again the values observed previously in
A549 cells [14]. While the high copper contents in the
cytoplasm could result both from remaining nanoparti-
cles not yet completely solubilized in the lysosomes as
well as from released copper ions, the even higher cop-
per concentration in the nucleus strongly indicates the
release of copper ions. These findings are in accordance
with the far higher solubility of CuO NP in the acidic
artificial lysosomal fluid (ALF) as compared to water or
cell culture media [14]. CuO MP were taken up to a
much lesser extent, but also in a concentration-
dependent manner, yielding lower concentrations also in
the cytoplasm and in the nucleus. Comparison to whole
cell copper contents without removal of the outer
membrane after particle treatment performed within this
study demonstrated that overestimation of cellular
copper levels would have been 3.5-fold in case of CuO
NP and even 70-fold in case of CuO MP. In contrast to
the particulate copper compounds, incubation with
CuCl2 provoked comparatively slightly elevated copper
levels in BEAS-2B cells. Especially in the nucleus almost
no increase was observed, indicating a tight homeostatic
control due to regulated uptake of copper ions. In con-
trast, higher nuclear copper levels have been observed in
A549 cells [14], which may be explained by the more
pronounced cytotoxicity in the latter cell line, leading to
uncontrolled copper influx. Consequently, endocytotic
uptake appears to circumvent copper homeostasis even
at non-cytotoxic concentrations, while in case of water
soluble copper compounds impaired homeostasis is
restricted to cytotoxic concentrations. Altogether, the
intracellular copper accumulation may be most decisive
for the toxicity of CuO NP.
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The systematic gene expression profiling via high-
throughput RT-qPCR displayed a concentration-
dependent impact of CuO NP on genes related to uptake
and genomic stability. The extent of modulation of the
uptake-related MT1X and MT2A genes, which are up-
regulated in response to copper ions via the metal re-
sponsive transcription factor MTF-1 [34, 35], reflected
the dose-dependent intracellular copper ion increase,
exerting distinct differences among the cell lines as well
as between the copper compounds. Thus, induction of
MT1X and MT2A by CuO NP was very distinct in case
of all investigated concentrations, higher than for CuO
MP and CuCl2 as well as more pronounced in BEAS-2B
cells as compared to A549 cells. Since metallothionein
gene induction is mediated by copper ions and not the
particulate compounds this is one clear indication of the
marked intracellular release of copper ions by the
particles.
Moreover, the up-regulation of oxidative and inflam-
matory response genes was more distinct in BEAS-2B
than in A549 cells and again most pronounced in case
of CuO NP; the concentration-dependent effects highly
corresponded to the intracellular copper accumulation.
The induction of the HMOX1 und HSPA1A genes is me-
diated via different redox-sensitive transcription factors
like Nrf2, HSF-1 and AP-1 [36–38] and can be regarded
as a model transcriptional response to the extent of ROS
generation and activation of the respective transcription
factors by the copper compounds. IL8 gene displayed
highest induction of all investigated genes by CuO NP in
BEAS-2B cells. This gene is known to be highly indu-
cible by NF-ΚB and AP-1 in response to pro-
inflammatory cytokines or cellular stress [39]. A pro-
inflammatory response via IL-8 release coincident with
an activation of AP-1 and NF-ΚB was further reported
in case of CuO NP in A549 cells [40] and was also ob-
served in A549 and HBEC cells using an in vitro air-
liquid interface exposure system [41]. An induction of
IL-8 was also described in response to TiO2 NP via NF-
ΚB and AP-1 activation in different lung cell lines, indi-
cating that oxidative stress may not be the only reason
to induce respective signalling pathways [42].
The induction of genes of the anti-oxidant defense sys-
tem, mainly regulated via Nrf2 [43], by CuO NP and to
a lesser extent by CuCl2 was restricted to BEAS-2B cells,
whereas the transcript levels were not altered or even re-
pressed in A549 cells. These differences between the cell
lines may be explained by lower levels of intracellular
glutathione in BEAS-2B cells as compared to A549 cells
[31–33, 44, 45] as well as by a persistent deregulation of
the expression of those anti-oxidative genes due to con-
stitutively active Nrf2 in A549 cells [29]. The proposed
activation of Nrf2 was confirmed in case of CuO NP for
all applied concentrations and in case of CuCl2 in high
cytotoxic doses in HeLa S3 cells. These cells were
chosen since they exert lower GSH levels as compared
to A549 cells [46] and are thus in this respect compar-
able to BEAS-2B cells, and no dysfunctional regulation
of Nrf2 has been reported. Since HeLa S3 cells are de-
rived from cervical adenocarcinoma, results obtained in
this cell line are not directly transferable to the lung cell
models; however, the results show that Nrf2 is in
principle activated by CuO NP and CuCl2. In support of
using HeLa S3 cells as a model for this specific question,
cytotoxicity as well as copper accumulation occurred to
a comparable extent as in BEAS-2B and A549 cells. The
induction of oxidative stress on the functional level was
further analysed via changes in intracellular GSH levels
in BEAS-2B cells. Accordingly, GSH depletion to 80% of
control was limited to CuO NP after 2 h treatment; in
case of CuCl2, after 24 h elevated intracellular GSH
levels were observed, indicative of up-regulation of GSH
synthesis and/or GSH reductase activity. These results
confirm previous studies reporting oxidative stress in-
duction, measured by enhanced ROS levels, changes in
GSH and GSSG, lipid peroxidation or modulated activ-
ities of anti-oxidant enzymes by CuO NP at different
time points [9, 47, 48].
With respect to genes associated with cell growth, cell
cycle regulation and apoptosis, increased mRNA levels
of the proto-oncogene JUN as well as the induction of
cell cycle inhibitor gene CDKN1A were restricted to
CuO NP in BEAS-2B cells. The positively auto-regulated
JUN [49–51] together with the induced IL8 and HMOX1
genes described above strongly indicates an activation of
AP-1 by CuO NP. In accordance with CDKN1A induc-
tion, a cell cycle arrest in G0/G1 phase was observed
after 8 h predominantly in case of CuO NP on the func-
tional level. The induction of the pro-apoptotic genes
PMAIP1 und TNFRSF10B was restricted to CuO NP in
BEAS-2B cells. Thus, genes coding for factors of both
the intrinsic and the extrinsic cascade were activated in
this cell line. However, the outcome concerning the
intrinsic pathway was conflicting by the concurrent
slight induction of genes of the anti-apoptotic Bcl-2
family. In contrast, in A549 cells only genes coding for
the intrinsic pathway were modulated, indicating a weak,
but clear pro-apoptotic signalling by a slight induction
of PMAIP1, coincident with decreased anti-apoptotic
BCL2 and BCL2L1 transcript levels. On the functional
level, cell death mediated by CuO NP and to a lesser
extent by CuO MP was necrotic and apoptotic, the latter
slightly more pronounced. Consistent with the gene
expression results the induction of apoptosis was re-
stricted to CuO NP in BEAS-2B cells, first evident after
48 h treatment. In A549 cells previous analyses revealed
the restriction of apoptosis to high concentrations of
more than 20 μg/mL CuO NP [14].
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Indicative for the induction of DNA damage, the DNA
damage response inducible genes DDIT3 and GADD45A
[52–54] were strongly up-regulated by CuO NP in
BEAS-2B cells, while only slight effects were observed in
case of CuO MP and CuCl2. Induction of these genes
was also evident in A549 cells, albeit to a lesser extent
and restricted to higher concentrations. The results are
in agreement with previous observations, demonstrating
enhanced expression of p38 and p53, indicative for DNA
damage, and the induction of DNA damage inducible
genes of the GADD family by CuO NP [19, 55]. The ac-
tivation of the DNA damage response is consistent with
the induction of DNA strand breaks by CuO NP mea-
sured via comet assay or alkaline unwinding [12, 14]. In
addition to genotoxicity, copper ions appear to inactivate
DNA repair processes. Thus, genes coding for specific
proteins in DNA repair pathways such as BER and NER
were down-regulated by CuO NP in BEAS-2B cells and
by both CuO NP and CuCl2 in A549 cells. In addition,
interactions of copper with distinct DNA repair proteins
have been described on the functional level, e.g. XPA in
NER and hOGG1 and PARP-1 in BER [56–58]. The in-
hibition of PARP-1 could further be confirmed by CuO
NP and CuO MP [14]. Despite the DNA damage signal-
ling, no activation of p53 appears to occur. Thus, no in-
duction of its inhibitor MDM2, which is
transcriptionally regulated by activated p53 [59], was ob-
served (data not shown). In BEAS-2B cells p53 is inacti-
vated as a consequence of the immortalization process
of this cell line [25]. In A549 cells the missing activation
was surprising since p53 is usually stabilized upon DNA
damage, regulating cell cycle arrest and apoptosis. How-
ever, in accordance with our findings Hanagata and co-
workers reported a minor role of p53 within gene ex-
pression induced by CuO NP [55].
As underlying mechanism of the observed oxidative
and genotoxic stress response the increased generation
of ROS due to elevated levels of redox-active copper
ions can be assumed [12, 13, 15, 19, 48]. Further interac-
tions leading for example to repressed transcript levels
of DNA repair genes could include a decrease in mRNA
stability, other post-translational mechanisms leading to
diminished protein levels or the direct interaction with
the respective transcription factors. Thus, due to the
high thiol affinity and redox-activity of copper ions
redox-sensitive cysteines inside or outside of zinc bind-
ing structures in transcription factors may display im-
portant targets of copper toxicity [60].
Conclusions
Within the present study, we confirmed the pronounced
cytotoxicity of CuO NP as compared to microsize CuO
particles or water soluble CuCl2 in human lung cell
lines. A CuO NP-mediated copper overload in the
cytoplasm and especially in the nucleus was shown to be
of major importance for the cytotoxic and genotoxic po-
tential as well as for dose-dependent transcriptional
changes of genes related to copper overload, (oxidative)
stress response, DNA damage response, cell growth and
cell cycle regulation and apoptosis. The high-throughput
RT-qPCR approach provided insight into the mode of
action of CuO NP and revealed relevant differences not
only between the copper compounds, but also between
the different cell lines. Importantly, it allowed the identi-
fication of dose-dependency; thus, while CuO NP
exerted effects already at low, non-cytotoxic concentra-
tions, changes in gene expression mediated by water sol-
uble CuCl2 were restricted to cytotoxic concentrations
with disturbed copper homeostasis. One underlying
mechanism appears to be increased intracellular
amounts of “free” reactive copper ions, consistent with
the “Trojan horse type mechanism”, which may lead to
elevated levels of ROS, but also direct oxidation of
redox-sensitive transcription factors such as critical cys-
teines in transcription factors. However, in addition to
intracellular copper ion release, interactions of the CuO
particles with the outer cell membrane cannot be com-
pletely excluded to contribute to the observed effects.
Also, within this study, comparisons were made based
on the copper content of the different compounds.
Nevertheless, the impact of different surface areas of the
nano- and microsized particles should be addressed. Fi-
nally, whether or not similar mechanisms account for
the toxicity of other metal-based nanoparticles needs to




Chemicals, including agarose, salts, glycerol, leupeptine,
phenylmethanesulfonyl-fluoride (PMSF), bovine serum
albumin, acids, snap-on lid glasses and stirring bars were
obtained from Carl Roth GmbH (Karlsruhe, Germany).
Copper chloride was purchased in high purity (>99.9%)
from Sigma-Aldrich Chemie GmbH (Steinheim,
Germany). All PCR consumables including PCR tubes,
strips and reaction tubes and tubules as well as cell cul-
ture dishes and flasks were obtained from Sarstedt
(Nuembrecht, Germany). The primer pairs were synthe-
sized by Eurofins (Ebersberg, Germany) or Fluidigm
(San Francisco, USA). DMEM, trypsin, amphotericin B,
trypsin inhibitor from Glycine max (soybean) (SBTI) and
penicillin-streptomycin solutions are products of Sigma-
Aldrich. Fetal calf serum (FCS) and LHC-9 media are
products of Invitrogen GmbH (Darmstadt, Germany).
Human fibronectin was obtained from Biopur (Reinach,
Switzerland) and collagen from Roche (Mannheim,
Germany). DNA suspension buffer, PCR certified water
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and TE buffer were obtained from Teknova (Hollister,
USA). 2X Assay Loading Reagent and 20X DNA Binding
Dye Sample Loading Reagent were purchased from Flui-
digm (San Francisco, USA). Bio-Rad (Munich, Germany)
provided the 2X SsoFast™ EvaGreen® Supermix with Low
ROX and the 2X SYBR Green Supermix. The 2X Taq-
Man® PreAmp Master Mix was obtained from Applied
Biosystems (Darmstadt, Germany) and the exonuclease I
from New England Biolabs (Frankfurt am Main,
Germany).
Particle characteristics
CuO NP (#544868, Lot #MKAA0633) and CuO MP
(#208841, Lot #MKAA1788) were purchased from
Sigma-Aldrich Chemie GmbH (Steinheim, Germany). A
detailed particle characterization using DLS with respect
to size, scanning electron microscopy (SEM) for size and
morphology, BET for surface area, ZP for surface charge,
ICP-MS, EDX and oxygen analysis for purity and com-
position as well as X-ray diffraction (XRD) for crystallin-
ity was described previously. Additionally, the impact on
pH in relevant media, endotoxin content and solubility
in different fluid models like H2O, DMEM, DMEM/10%
FCS, PBS, AAF and ALF was investigated [14].
Particle and CuCl2 incubation suspensions and dilutions
Fresh CuO NP, CuO MP suspensions and CuCl2 dilu-
tions were prepared for each experiment. Particles, re-
ceived as dry powder, were aliquoted by weighing into
1.5 mL polystyrene reaction tubes. Stock solutions of
1 mg/mL CuO were prepared into an endotoxin-free
snap-on glass containing a stirring bar in DMEM con-
taining 10% FCS. Dilutions in the range of 1–50 μg/mL
were prepared by adding aliquots of the stirring stock
solution into snap-on lid glasses filled with adequate vol-
umes of fresh medium. Stirring took place at 900 rpm
and room temperature on a multiphase stirrer (Vario-
mag Poly, Carl Roth GmbH, Karlsruhe, Germany). CuCl2
was dissolved in bidistilled H2O (100 mM) and sterile-
filtered. Dilutions in the range of 12.6–630 μM corre-
sponding to the identical mass doses of copper per mL
of the particulate CuO were prepared from the stock so-
lution by dilution in adequate amounts of DMEM con-
taining 10% FCS directly before incubation. 1 μg/mL
CuO is equal to 0.2 μg/cm2 CuO and 12.6 μM Cu2+ in
case of complete dissolution.
Cell culture and incubation
The adherent human adenocarcinoma cell line A549
(ATCC CCL-185) and human cervix adenocarcinoma
cell line HeLa S3 (ATCC CCL-2.2) were obtained from
ATCC and cultured as monolayer in DMEM containing
10% FCS, 100 U/mL penicillin and 100 mg/mL strepto-
mycin. Human lung bronchial epithelial BEAS-2B cells
(ATCC CRL-9609), immortalized with SV40 large T-
antigen, were kindly provided by Dr. Carsten Weiss
(Karlsruhe Institute of Technology, Karlsruhe,
Germany). They were grown as monolayers in coated
cell culture dishes (10 μg/mL human fibronectin, 30 μg/
mL collagen and 10 μg/mL bovine serum albumin in
PBS) in LHC-9 medium containing 2.5 μg/mL ampho-
tericin B. Cells were incubated at 37 °C in a humidified
atmosphere of 5% CO2 in air. For all experiments cells
were seeded at a density of 16.600 cells/cm2. After 24 h
of cultivation in case of A549 and HeLa S3 cells and
48 h in case of BEAS-2B cells the supernatant from the
logarithmically growing cells was removed and replaced
by the particle and CuCl2 incubation suspensions or di-
lutions (0.2 mL/cm2) in DMEM containing 10% FCS in-
dependent from the respective cell culture medium to
ensure comparable incubation conditions for all applied
cell lines.
Cell number
Logarithmically growing BEAS-2B cells were incubated
for 24 h with 1–50 μg/mL CuO NP or CuO MP or
12.6–630 μM CuCl2, respectively, trypsinized and col-
lected in DMEM containing 10% FCS. Cell number was
determined via Casy® cell counter (OLS OMNI Life Sci-
ence GmbH & Co. KG, Bremen, Germany).
Cellular uptake and intracellular distribution
Logarithmically growing BEAS-2B cells were treated
with different concentrations of CuO NP, CuO MP and
CuCl2 for 24 h in DMEM containing 10% FCS. The cells
were trypsinized, collected in ice-cold PBS containing
10% FCS, washed twice with PBS and counted via Casy®
cell counter for cell number and cell volume. For deter-
mination of copper in the soluble fraction of the whole
cells, they were lysed in RIPA buffer (0.01 M Tris
pH 7.6, 0.15 M NaCl, 0.001 M EDTA, 1% (v/v) Trition-
X 100, 1% (v/v) DOC, 0.01% SDS, 0.001 M PMSF, 1 x
protease-inhibitor mixture) for 30 min before centrifuga-
tion at 14.000 x g (1 h, 4 °C). The supernatant contained
the soluble fraction and was used for graphite furnace
atomic absorption spectrometry (GF-AAS). Soluble cyto-
plasmic and nuclear fractions were prepared using a
method described previously [14, 27]. Briefly, cells were
allowed to swell in cell lysis buffer (0.01 M HEPES
pH 7.9, 0.01 M KCl, 0.0015 M MgCl2, 0.3 M saccharose,
0.0005 M dithiothreitol (DTT), 0.0006 M PMSF,
0.0065 mM Leupeptine) for 15 min before the addition
of 25 μL 10% (v/v) IGEPAL CA 630 (Fluka) in H2O for
cell lysis. The mixture was vortexed for 10 s and the nu-
clei pelleted at 1500 x g (15 min, 4 °C). The supernatant
contained the soluble cytoplasmic fraction and was used
for GF-AAS. The nuclei-containing pellet was washed
twice with cell lysis buffer. Subsequently the volume and
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number of the nuclei was determined via Casy® cell
counter and the soluble content was extracted by treat-
ment with nuclear lysis buffer (0.01 M HEPES pH 7.9,
0.4 M KCl, 0.0015 M MgCl2, 15% (w/v) glycerol,
0.0005 M DTT, 0.0006 PMSF, 0.0065 mM Leupeptine)
for 30 min on ice after mixing and subsequent centrifu-
gation at 10.000 x g (30 min, 4 °C). The supernatant
contained the soluble nuclear fraction and was used for
GF-AAS. All cellular soluble fractions were evaporated
at 95 °C, incubated with ashing mixture, 65% HNO3/
30% H2O2 (1/1), evaporated at 95 °C again and resolved
in water. Copper content was determined using GF-AAS
(Perkin Elmer Atomic Absorption Spectrometer PinAA-
cle 900 T). Recovery rates were determined in the re-
spective matrix using AAS elemental standard solutions
(Carl Roth AG) and reached 101% ± 6% (external stand-
ard), 99% ± 4% (total fraction), 96% ± 6% (cytoplasmic
fraction) and 99% ± 4% (nuclear fraction). Copper con-
tent was normalized to cell number and volume.
Gene expression analyses
Gene expression analyses via high-throughput RT-qPCR
with Fluidigm dynamic arrays on the BioMark™ System
were performed as described previously [24]. Briefly,
0.35–1 × 106 logarithmically growing A549 or BEAS-2B
cells were treated with different concentrations of CuO
NP, CuO MP and CuCl2 for 24 h in DMEM containing
10% FCS. After incubation, cells were trypsinized, resus-
pended in ice-cold PBS containing 10% FCS, collected
by centrifugation, washed with ice-cold PBS and col-
lected again by a second centrifugation step. Total RNA
was isolated with MN NucleoSpin® RNA Plus KIT
(Macherey-Nagel) according to the manufacturer’s in-
structions and quantified. 1 μg of total RNA was reverse
transcribed in duplicate per sample into first-strand
complementary DNA (cDNA) using qScript™ cDNA
Synthesis Kit (Quanta) according to the manufacturer’s
instructions. During high-throughput qPCR all pipetting
steps were carried out in a separate room under decon-
taminated and sterile conditions in a PCR Workstation
Pro (Peqlab, Erlangen, Germany). Before qPCR, specific
target amplification (STA) and exonuclease I (E. coli)
treatment had to be performed. A total of 5 μL STA mix
was prepared containing 2.5 μL 2X TaqMan® PreAmp
Master Mix, 0.5 μL of the 500 nM pooled primer mix-
ture, 0.75 μL PCR certified water and 1.25 μL cDNA per
reaction. A PCR certified water control (NTC-STA) and
a non reverse-transcribed RNA control (NoRT) were in-
cluded. STA was performed in a thermal cycler (T100,
Bio-Rad Laboratories, Munich, Germany) using the fol-
lowing temperature program: 10 min at 95 °C followed
by 12 cycles of 15 s at 95 °C and 4 min at 60 °C and a
final holding temperature of 4 °C. Afterwards, 0.4 μL
exonuclease I (Exo I) at 20 units/μL was diluted to
4 units/μL with 0.2 μL 10X Exonuclease I Reaction Buf-
fer and 1.4 μL PCR certified water per reaction. 2 μL of
the Exonuclease Reaction Mixture were added to the
STA samples and digestion with Exo I at 4 units/μL was
performed using the following temperature program:
40 min at 37 °C, 15 min at 80 °C and a final holding
temperature at 4 °C. STA and Exo I-treated samples
were diluted 5-fold with 18 μL TE buffer. For qPCR for-
ward and reverse primers (100 μM) were diluted to
5 μM by adding 2.5 μL of each primer pair to 25 μL of
2X Assay Loading Reagent and 22.5 μL of DNA suspen-
sion buffer. The primer reaction mix was stored at −20 °
C. For the sample mix, 2.25 μL of STA and Exo I-treated
samples were mixed with 2.5 μL of 2X SsoFast™ Eva-
Green® Supermix with Low ROX and 0.25 μL of 20X
DNA Binding Dye Sample Loading Reagent. Preparation
and loading of Fluidigm 96.96 Dynamic Array IFC (inte-
grated fluidic circuit) was performed according to the
manufacturer’s instructions. After priming, the chip was
loaded with samples and the primer reaction mixes
within 1 h to reduce the loss of the pressure within the
chip. Thus, 5 μL of each primer reaction mix and each
sample were pipetted into the respective inlets, avoiding
the generation of air bubbles. Samples and primer reac-
tion mixes were loaded into the chip by running the
Load Mix (136×) script of the IFC Controller HX (Flui-
digm, San Francisco, USA). After loading of the chip,
potential dust particles were carefully removed from the
surface of the chip using adhesive tape. The chip was
transferred into the BioMark™ System (Fluidigm, San
Francisco, USA) and qPCR and melting curve analysis
were performed by running the following temperature
program: 2400 s at 70 °C and 30 s at 60 °C, followed by
a hot start for 60 s at 95 °C, 30 PCR cycles of 5 s at 96 °C
for denaturation and 20 s at 60 °C for annealing and
elongation. The melting curve analysis consisted of 3 s at
60 °C followed by heating up to 95 °C with a ramp rate of
1 °C/3 s. Data analysis and depiction was accomplished
with the Fluidigm Real-Time PCR Analysis and with
GenEx software. For normalization, five potential refer-
ence genes were available (ACTB, B2M, GAPDH, GUSB,
and HPRT1). Finally, potential alterations of the transcript
levels of the target genes under investigation were dis-
played as fold change compared to a control group by cal-
culating relative quantities corresponding to the ΔΔCq
method [61].
Quantification of intracellular glutathione
The quantification of intracellular glutathione levels was
performed according to the method established by
Tietze et al. [28]. Briefly, logarithmically growing BEAS-
2B cells were incubated for 2 h or 24 h, respectively,
with 1–20 μg/mL particulate CuO or 12.6–252 μM
CuCl2, respectively, in DMEM containing 10% FCS. The
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cells were trypsinized, collected in ice-cold PBS contain-
ing 10% FCS, washed with PBS, counted via Casy® cell
counter for cell number and cell volume and collected
by centrifugation. 1 × 106 cells were collected in KP buf-
fer (0.1 M KH2PO4, 0.1 M K2HPO4, 1 mM EDTA,
pH 7.4). Cells were lyzed by 2 freeze-and-thawing cycles
followed by sonification, followed by acidification with
sulphosalicyclic acid and vortexed. Cells were centri-
fuged at 16.000 rpm for 20 min at 4 °C prior to measur-
ing total GSH in the supernatant by reducing oxidized
GSH content using GR enzyme (4 U/mL) and NADPH
(0.3 mM). Thereby, GSH reacts with 5,5′-dithiobis-2-
nitrobenzoic acid (DTNB) to form 2-nitro-5-thiobenzo-
ate (TNB). The change in TNB absorbance was
measured at 412 nm using a plate reader (Tecan). Data
were compared to GSH standard calibration curves and
normalized to cell volume.
Nrf2 activity
Logarithmically growing HeLa S3 cells were treated with
different concentrations of CuO NP, CuO MP and CuCl2
for 5 h in DMEM containing 10% FCS. Nuclear extracts
were prepared using a nuclear extract kit (Active Motif,
Carlsbad, CA, USA) according to the manufacturer’s in-
structions. Thus, cells were washed with ice-cold PBS/
phosphatase inhibitors, scraped into ice-cold PBS/phos-
phatase inhibitors buffer and collected by centrifugation.
The cells were lyzed in hypotonic buffer and swelled on
ice for 15 min. After addition of detergent and vortexing,
cells were centrifuged at 14.000 x g for 30 s at 4 °C. The
supernatant (containing the cytoplasmic fraction) was
stored separately and the nuclear pellet was resuspended
in Complete Lysis Buffer containing detergent, mixed
and incubated for 30 min on a rocking platform at
150 rpm. Afterwards, the nuclear pellets were vortexed
and centrifuged at 14.000 x g for 20 min at 4 °C. The
supernatant containing the nuclear extract was used for
the determination of Nrf2 activity after determining pro-
tein content according to the method established by
Bradford [62]. Nrf2 activity was determined with the
TransAM Nrf2 assay (Active Motif, Carlsbad, CA, USA)
according to the manufacturer’s instructions. Nuclear
extracts (5 μg) were incubated with ARE consensus site
oligonucleotides (5′-GTCACAGTGACTCAGCAGAAT
CTG-3′) immobilized to 96-well plates. Bound protein
levels were quantified by antibody specific to DNA-
bound Nrf2 and visualized by colorimetric reaction cata-
lysed by horseradish-peroxidase-conjugated secondary
antibody. Resulting absorbance was measured at 405 nm
with a reference wave length of 655 nm.
Cell cycle analysis and cell death induction
0.35–1 × 106 logarithmically growing BEAS-2B cells
were treated with different concentrations of CuO NP,
CuO MP and CuCl2 for 8, 24 or 48 h in DMEM contain-
ing 10% FCS. Cells were trypsinized, collected in fresh
media, combined with the supernatant and centrifuged
at 1300 rpm for 3 min at 4 °C. Respective parts of the
cell suspension were used for cell death or cell cycle
analysis. Concerning the latter, the pellet was resus-
pended in 1 mL ice-cold PBS before 3 mL ice-cold etha-
nol (96%) were added under vortexing, followed by
fixation overnight at −20 °C. For flow cytometry analysis,
the cells were collected by centrifugation, washed with
1 mL PBS and centrifuged again. The pellet was resus-
pended in 300 μL DAPI dye solution (CyStainDNA, Par-
tec) and incubated for 30 min at 4 °C in the dark. For
cell death analysis, the cell suspension was directly
stained with a master mix (PI and annexin V-FITC in
calcium buffer, pH 7.0) and incubated for 30 min at 4 °C
in the dark. 10.000 or 30.000 cells per sample were ana-
lysed for cell death induction or DAPI intensity, respect-
ively, via flow cytometry using a LSR Fortessa from
Becton Dickinson. Excitation and emission detection of
the applied fluorescence dyes were as follows: DAPI
(405 nm - 450/50 nm), PI (488 nm – 695/40 nm) and
annexin V-FITC (488 nm – 530/30 nm).
Statistics
Differences between control and treated samples were
analysed by one-way analysis of variance (ANOVA)
followed by Dunnett’s T posthoc test.
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